The Administrative Core will provide management and leadership to the Oklahoma Autoimmunity Center of Excellence (Oklahoma ACE) allowing for expedited translation of basic science advances into clinical application in the diagnosis and treatment of systemic autoimmune disease. In support of this goal, the Administrative Core will serve as the centralized coordinating resource for the ACE. Based upon its previous success, the Oklahoma ACE will continue to host a weekly Autoimmunity Forum, bringing together the 14 basic scientists and 12 clinical investigators, representing a number of different clinical specialties and complementary research areas, who serve as part of the Oklahoma ACE, as well as their trainees and other interested parties. We will also continue to invite ACE investigators from the rest of the ACE network to help forge and facilitate inter-ACE collaborations^ To accomplish these goals, the Administrative Core will focus on the following Services: 1) provide central management for the Oklahoma ACE components and activities; 2) facilitate interactions of the Oklahoma ACE with the ACE Network and the NIH ACE Program; 3) promote multidisciplinary approaches to research; and 4) promote data sharing strategies. The Core Leader will facilitate communication among the ACE community, ensure compliance with all NIH policies, and provide a foundation for scientific growth in translational and basic research. The Administrative Core Leader will oversee all administrative and personnel issues, work with ACE investigators to resolve issues, review project progress, and assist in grant applications and publications developed by ACE investigators. The Core Leader will attend ACE Steering Committee meetings and be the primary contact for the NIH ACE Program. The Core Leader and administrative staff will be responsible for preparing and submitting all annual progress reports and just-in-time and other information as needed to the NIH. Through the assistance ofthe OMRF grants accounting office, the Core Leader and administrative staff will also be responsible for managing the Oklahoma ACE budget. The Administrative Core services will optimize the use of funding and ensure that the Oklahoma ACE goals are met in a timely manner.

Public Health Relevance

The Oklahoma ACE is comprised of a multidisciplinary team of physician scientists and basic science investigators with the common goal of improving autoimmune disease patient care through expediting the translation of basic science findings into clinical applications. The Administrative Core will provide the, Oklahoma ACE with centralized leadership and management.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI082714-09
Application #
9269142
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2017-05-01
Budget End
2018-04-30
Support Year
9
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
077333797
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Kheir, Joseph M; Guthridge, Carla J; Johnston, Jonathon R et al. (2018) Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosus. Lupus Sci Med 5:e000247
Young, K A; Munroe, M E; Harley, J B et al. (2018) Less than 7 hours of sleep per night is associated with transitioning to systemic lupus erythematosus. Lupus 27:1524-1531
Jog, Neelakshi R; Chakravarty, Eliza F; Guthridge, Joel M et al. (2018) Epstein Barr Virus Interleukin 10 Suppresses Anti-inflammatory Phenotype in Human Monocytes. Front Immunol 9:2198
Fu, Yao; Tessneer, Kandice L; Li, Chuang et al. (2018) From association to mechanism in complex disease genetics: the role of the 3D genome. Arthritis Res Ther 20:216
Hanscombe, Ken B; Morris, David L; Noble, Janelle A et al. (2018) Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans. Hum Mol Genet 27:3813-3824
Bagavant, Harini; Dunkleberger, Micah L; Wolska, Nina et al. (2018) Antibodies to periodontogenic bacteria are associated with higher disease activity in lupus patients. Clin Exp Rheumatol :
Wang, Chih-Chuan; Ortiz-González, Xilma R; Yum, Sabrina W et al. (2018) ?IV Spectrinopathies Cause Profound Intellectual Disability, Congenital Hypotonia, and Motor Axonal Neuropathy. Am J Hum Genet 102:1158-1168
Scofield, R Hal; Sharma, Rohan; Harris, Valerie M (2018) Reply. Arthritis Rheumatol 70:626-627
Glauzy, Salomé; Boccitto, Marco; Bannock, Jason M et al. (2018) Accumulation of Antigen-Driven Lymphoproliferations in Complement Receptor 2/CD21-/low B Cells From Patients With Sjögren's Syndrome. Arthritis Rheumatol 70:298-307
St Clair, E William; Baer, Alan N; Wei, Chungwen et al. (2018) Clinical Efficacy and Safety of Baminercept, a Lymphotoxin ? Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol 70:1470-1480

Showing the most recent 10 out of 133 publications